PTK2 and mesothelioma: Preclinical studies have demonstrated that mesothelioma cells lacking NF2 are sensitive to inhibitors of focal adhesion kinase (FAK), which disrupts the interaction of FAK with SRC and the p85 regulatory subunit of PI3K [30].